The Journal of Alzheimer’s Disease has launched a new feature, “Ethics Review,” which will provide support and guidance to move ethical decision-making forward. The goal is to create a forum for dementia researchers, clinicians and policy makers to bring greater clarity and constructive discussion to define risks and benefits from the perspectives of diverse disciplines.

This new section will be guided by Allyson C. Rosen, PhD, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA, USA, and Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA.

The first contribution, Ethics Review as a Catalyst for Progress by Allyson C. Rosen, John Wesson Ashford and George Perry, focuses on how ethical decision-making can become more efficient and better informed and thereby contribute to advancing research and clinical work in AD.

Instructions to Authors